Company research
Vigil Neuroscience, Inc.
CIK 1827087Updated Sep 26, 2026
Securities
Historical securities (1)
VIGL · OTC · equity · closed Aug 4, 2025VIGL price & chart
Historical security
This listing closed Aug 4, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
No filing activity has been returned.
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 117,691,000Source | 140,858,000Source | 200,393,000Source | 102,441,000Source |
| Property, Plant and Equipment, NetUSD | 1,319,000Source | 1,745,000Source | 1,184,000Source | 301,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 39,019,000Source | 51,992,000Source | 186,605,000Source | 91,420,000Source |
| Assets, CurrentUSD | 100,584,000Source | 121,907,000Source | 197,805,000Source | 97,483,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,789,000Source | 3,967,000Source | 11,200,000Source | 6,063,000Source |
| Operating Lease, Right-of-Use AssetUSD | 14,740,000Source | 16,147,000Source | 141,000Source | 882,000Source |
| Other Assets, NoncurrentUSD | 93,000Source | 83,000Source | 266,000Source | 2,757,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 46,056,000Source | 24,606,000Source | 11,312,000Source | 9,945,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 4,000Source | 4,000Source | 4,000Source | — |
| Retained Earnings (Accumulated Deficit)USD | -307,028,000Source | -222,772,000Source | -140,134,000Source | -71,829,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 27,000Source | -5,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 71,635,000Source | 116,252,000Source | 189,081,000Source | -69,443,000Source |
| Additional Paid in Capital, Common StockUSD | 378,632,000Source | 339,025,000Source | 329,211,000Source | 2,386,000Source |
| Liabilities and EquityUSD | 117,691,000Source | 140,858,000Source | 200,393,000Source | 102,441,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 34,147,000Source | 11,661,000Source | 11,312,000Source | 9,881,000Source |
| Operating Lease, Liability, CurrentUSD | 1,036,000Source | 905,000Source | — | — |
| Accounts Payable, CurrentUSD | 1,967,000Source | 1,946,000Source | 1,942,000Source | 3,977,000Source |
| Operating Lease, Liability, NoncurrentUSD | 11,909,000Source | 12,945,000Source | — | 41,000Source |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -84,256,000Source | -82,638,000Source | -68,305,000Source | -43,283,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 10,117,000Source | 8,903,000Source | 5,477,000Source | 2,085,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 21,000Source | 5,000Source | -2,478,000Source | 2,350,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -51,223,000Source | -70,363,000Source | -65,149,000Source | -39,347,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 8,760,000Source | -65,138,000Source | -921,000Source | -204,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 5,000Source | 674,000Source | 921,000Source | 204,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 29,490,000Source | 888,000Source | 161,255,000Source | 107,747,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -12,973,000Source | -134,613,000Source | 95,185,000Source | 68,196,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 39,946,000Source | 52,919,000Source | 187,532,000Source | 92,347,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 10,117,000Source | 8,903,000Source | 5,477,000Source | 2,085,000Source |
| Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously RecordedUSD | 0Source | 0Source | — | — |
| DepreciationUSD | 432,000Source | 378,000Source | 57,000Source | 15,000Source |
| General and Administrative ExpenseUSD | 27,377,000Source | 27,932,000Source | 21,440,000Source | 10,079,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Investment Income, InterestUSD | 5,418,000Source | 6,241,000Source | 623,000Source | 3,000Source |
| Net Income (Loss) Attributable to ParentUSD | -84,256,000Source | -82,638,000Source | -68,305,000Source | -43,283,000Source |
| Nonoperating Income (Expense)USD | 5,427,000Source | 6,228,000Source | 579,000Source | -874,000Source |
| Operating ExpensesUSD | 89,683,000Source | 88,866,000Source | 68,884,000Source | 42,409,000Source |
| Operating Lease, ExpenseUSD | 2,400,000Source | 2,400,000Source | — | — |
| Other Nonoperating Income (Expense)USD | 9,000Source | -13,000Source | -44,000Source | -13,000Source |
| Proceeds from Issuance of Common StockUSD | 9,542,000Source | — | 50,594,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 138,000Source | 911,000Source | 154,000Source | 38,000Source |
| Realized Investment Gains (Losses)USD | 16,000Source | 8,000Source | — | — |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -89,683,000Source | -88,866,000Source | -68,884,000Source | -42,409,000Source |
| Other Nonoperating Income (Expense)USD | 9,000Source | -13,000Source | -44,000Source | -13,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -84,256,000Source | -82,638,000Source | -68,305,000Source | -43,283,000Source |
| Earnings Per Share, BasicUSD per share | -2.07Source | -2.13Source | -2.16Source | -28.26Source |
| Earnings Per Share, DilutedUSD per share | -2.07Source | -2.13Source | -2.16Source | -28.26Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 40,668,444Source | 38,712,207Source | 31,685,125Source | 1,531,686Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 40,668,444Source | 38,712,207Source | 31,685,125Source | 1,531,686Source |
| Additional Financial Items | ||||
| Depreciation, Depletion and Amortization, NonproductionUSD | 453,000Source | 399,000Source | 78,000Source | 28,000Source |
| General and Administrative ExpenseUSD | 27,377,000Source | 27,932,000Source | 21,440,000Source | 10,079,000Source |
| Investment Income, InterestUSD | 5,418,000Source | 6,241,000Source | 623,000Source | 3,000Source |
| Nonoperating Income (Expense)USD | 5,427,000Source | 6,228,000Source | 579,000Source | -874,000Source |
| Operating ExpensesUSD | 89,683,000Source | 88,866,000Source | 68,884,000Source | 42,409,000Source |
| Operating Lease, ExpenseUSD | 2,400,000Source | 2,400,000Source | — | — |
| Realized Investment Gains (Losses)USD | 16,000Source | 8,000Source | — | — |
| Research and Development ExpenseUSD | 62,306,000Source | 60,934,000Source | 47,444,000Source | 32,330,000Source |